Sightsavers Ceo Salary, Don Hanna Marching Contest Results 2021, Articles M

Seminal contributions include the identification of IDH1 and IDH2 mutations in chondrosarcomas and enchondromas, including the characterization of IDH1/2 somatic mosaic mutations as the cause of Ollier disease and Maffucci syndrome; discoveries regarding the pathogenesis of chordomas; the identification of the role of H3F3A and H3F3B driver mutations in chondroblastoma and giant cell tumor of bone; the identification of the frequent mutation of the major cartilage collagen gene, COL2A1, in chondrosarcoma; and the identification of recurrent PTPRB and PLCG1 mutations in angiosarcoma. UserID@mskcc.org. in conjunction with IU Health Physicians is seeking an experienced anatomic or surgical pathologist to serve as Vice Chair of Anatomic Pathology. Dr. Huntsmans group has also contributed to the identification and study of driver mutations in rare tumors, such as the FOXL2 mutation in adult-type granulosa cell tumors of the ovary, DICER1 mutations in a series of rare testicular and ovarian cancers, and SMARCA4 mutations in small cell hypercalcemic carcinomas of the ovary. memorial sloan kettering pulmonary critical care fellowship; what happened to brittany on kqrs radio; how to install hdoom; cus d'amato house catskill address; obsessing over past mistakes ocd; your network administrator might have ended the connection; nba 2k10 player ratings; shotgun sights for pheasant hunting; alice et juliette bourbion 12 . As the convener and major force behind the 2005 and 2014 conferences on prostate cancer grading, Dr. Epstein is considered the international authority on the subject. Easy 1-Click Apply (MEMORIAL SLOAN KETTERING CANCER CENTER) Assistant to Chair, Sloan Kettering Institute job in New York, NY. Dr. Ferrell is also an ardent educator. Monday to Friday, 8 a.m. to 6 p.m. (Eastern time), Monday to Friday, 9 a.m. to 5 p.m. (Eastern time). We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. 21 2021. No other requests will be acknowledged. mskcc pathology chair early childhood conferences 2022 florida mediacom tv everywhere roku . . Internal Number: 22016822. Take a tour of our Center for Laboratory Medicine. A gifted morphologist, Dr. Gerald was committed to providing state-of-the-art patient care as a surgical pathologist and recognized that the molecular characterization of human neoplasms could affect the classification, prognostic assessment, and treatment of cancer. This repository provides source code for ovarian cancer segmentation using Deep Multi-Magnification Network. Dr. Iafrate has been a superb educator and supportive mentor for countless pathology trainees and is a gifted speaker. The Pathology Core also implements stringent quality control standards to ensure consistent, valid services for investigators using the shared resource. In 2001, Dr. Huntsman showed that gastrectomy samples from germline CDH1 mutation carriers who underwent prophylactic gastrectomy often revealed multiple foci of occult carcinomas. MSK CME, 2023 Digital Pathology Course, 5/5/2023 12:30:00 PM - 5/6/2023 1:30:00 PM, Over recent years, digital pathology is emerging as a next generation "standard of care pathology practice" through scanning, reviewing, and storing of pathology slides in a digital format. This powerful technology has proved capable not only of accurately pigeon-holing many neoplasms of poorly differentiated or otherwise ambiguous morphology, but suffices to identify clinically relevant subtypes within tumor categories (e.g., Wnt or SHH-driven medulloblastomas, RELA- fused ependymomas and C19MC- altered embryonal tumors with multilayered rosettes). She did fellowship training at the University of California, San Francisco (UCSF), then joined the faculty there, remaining at the university until 2015, when she retired to emeritus status. From diagnosis to treatment, our experts provide the care and support you need, when you need it. His work helped establish a novel molecular classification of neuroblastoma. Our highly-specialized educational programs shape leaders to be at the forefront of cancer care and research. Join our talent community to receive updates on new and noteworthy happenings at MSK. In addition, Dr. Iafrate has led major laboratory efforts, particularly in the areas of lung and brain cancers as well as human germline genetics. From left: Then Chair of the Department of Pathology Frank Foote, Jr.; Fred W. Stewart; and Sophie Spitz. Have greater competence related to. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need, when you need it. The Department of Medicine, the largest of Memorial Sloan Kettering's clinical departments, encompasses nearly 500 faculty members in four divisions including Hematologic Malignancies, Solid . Assistant Director, Transfusion Medicine and Cell Therapy, Director, Center for Cell Engineering; Stephen and Barbara Friedman Chair, Pursuing basic and translational research across 9 programs and 100+ labs, Focusing on clinical cancer research and population health, Bridging the lab and the clinic through translational research, Fostering interdisciplinary collaborations between laboratory scientists and clinicians, Partnering with other academic and research institutions, Offering state-of-the-art resources for our researchers, Offering a curriculum with a focus on cancer, Connecting college seniors to future careers in biomedicine, More About Department of Pathology and Laboratory Medicine, The Warren Alpert Center for Digital and Computational Pathology at MSK, 2023 Memorial Sloan Kettering Cancer Center, Human Oncology & Pathogenesis Program (HOPP), Gerstner Sloan Kettering Graduate School of Biomedical Sciences, High school & undergraduate summer programs, Department of Pathology and Laboratory Medicine, The MSK Pathology & Laboratory Medicine Review , Research collaborations with the Last Wish Program, Learn more about the Surgical Pathology Team. After several highly productive years as a Consultant in that department, Dr. von Deimling went on to assume Directorship of the Department of Neuropathology, Charite, Berlin (1998-2006) before being recruited to his current Chair position at Heidelberg. Monday to Friday, 8 a.m. to 6 p.m. (Eastern time), Monday to Friday, 9 a.m. to 5 p.m. (Eastern time). Dr. Flanagan is also the director of UCL Advanced Diagnostics, which provides services to both clinicians for their diagnoses and researchers, allowing the transition from discovery to diagnostics. Were always looking for laboratory experts who specialize in: Cell therapy Clinical Chemistry Clinical Hematology and Immunology Clinical Microbiology and infectious disease Hematopathology Transfusion MedicineBecause Laboratory Medicine handles testing needs system-wide, we have more than one lab across MSK. Scott Porsenna's Phone Number and Email Last Update. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey. MSK Telemedicine Dashboard. Chair, Molecular Pharmacology Derek Tan Chair, Chemical Biology Former Department Chairs Philip Kantoff Former Chair, Department of Medicine David S. Klimstra Former Chair, Department of Pathology Elizabeth McCormick Senior Vice President and Chief Nursing Officer Peter Scardino Emeritus Richard J. O'Reilly It is only fitting that Dr. Hruban and his colleagues were recognized for their efforts as recipients of the prestigious Team Science Award from the American Association for Cancer Research. Our highly-specialized educational programs shape leaders to be at the forefront of cancer care and research. Chair, Department of Pathology and Laboratory Medicine, Vice Chair of Clinical Integration, Department of Laboratory Medicine, Director, Precision Pathology Biobanking Center, Director, Neuropathology; Founder's Chair, Vice Chair, Department of Pathology; Director, Genitourinary Pathology; Director, Genitourinary Pathology Fellowship, Chair, Graduate Medical Education Committee; Director, Gynecologic Pathology Fellowship Program, Chief, Molecular Diagnostics Service; William J. Ruane Chair in Molecular Oncology, Vice Chair of Clinical Operations, Department of Laboratory Medicine, Medical and Scientific Director, Histocompatibility Laboratory; Assistant Laboratory Director, Transfusion Services, Josie Robertson Surgical Center, Assistant Director, Clinical Hematology Laboratories; Director, MSK Commack Clinical Laboratory; Director, MSK Nassau Clinical Laboratory, Director, Fine Needle Aspiration Biopsy Clinic, Director, Last Wish Program; Co-Director, Clinical Autopsy Program; Medical Director, MSK-Hunter College Advanced Certificate in Cytotechnology Program, Director, Gastrointestinal Pathology Fellowship Program, Chief, Hematopathology Service, Department of Pathology and Laboratory Medicine, Program Director, Molecular Genetic Pathology Fellowship, Director, Diagnostic Molecular Pathology Laboratory, Co-Director, Marie-Jose & Henry R. Kravis Center for Molecular Oncology; Attending, Molecular Diagnostics Service, Department of Pathology, Director, Diagnostic Molecular Genetics Laboratory. Dr. Flanagan has also made significant contributions to the field of cancer genetics as part the Wellcome Trust Sanger Institutes cancer genome sequencing effort. He then pursued multidisciplinary training in anatomic and clinical pathology and clinical molecular genetics in Canada and clinical oncology and cancer genetics at the University of Cambridge. Email. Vice Chair of Research - Heart & Vascular Institute . James Ewing Alumni Chair, Department of Pathology, Memorial Sloan Kettering Cancer Center (2022) Inaugural Peter C. Nowell, MD, Chair, Founding Director, Center for Personalized Diagnostics, University of Pennsylvania President, Association for Molecular Pathology (2017-2018) The Department of Pathology and Laboratory Medicine at Memorial Sloan Kettering Cancer Center consists of disease-specific pathologists, molecular diagnosticians, clinical laboratory testing experts, educators, and researchers with expertise and focus in cancers affecting both adult and pediatric patients. Dr. Spitz was most famous for her discovery of juvenile melanoma, which is now known as Spitz nevi. Kojo Elenitoba-Johnson is the inaugural Peter C. Nowell, MD Professor at the Perelman School of Medicine at University of Pennsylvania. Dr. Hruban has also made his mark in other fields, as he has produced an award-winning documentary on William Stewart Halsted and an audio series called Osler Minutes on the philosophy of William Osler. Legal Disclaimer | Giving to the Library He was approachable and always willing to provide key insights. While his name is synonymous with every major academic effort in the GU Pathology community over the past three decades, including editorship of and significant contributions to the 2004 and 2016 World Health Organization GU tumor classification, he is best known for his work in prostate pathology spanning all major aspects of the disease. Monday to Friday, 8 a.m. to 6 p.m. (Eastern time), Monday to Friday, 9 a.m. to 5 p.m. (Eastern time). Today, as we celebrate the memory of Dr. Fred Waldorf Stewart, a pathologist, who in his time, made significant contributions to the care of cancer patients, we are proud to bestow this years Award on a former MSKCC Oncologic Surgical Pathology fellow and leader in his field, Dr. Jonathan I. Epstein, who is supremely deserving of recognition for his immense contributions to the surgical pathology of the GU tract and specifically, prostate cancer and its clinical ramifications. Site Navigation. Memorial Sloan Kettering was founded in 1884, and today is a world leader in patient care, research, and educational programs. In addition to being a Program Chair, Dr, Lowe is also the Chair of the Geoffrey Beene Cancer Research Center; and an Investigator, at Howard Hughes Medical Institute. Pathology Robert Larner, M.D. Your next opportunity could be right here. The two decades following these initial efforts saw Dr. Hruban diving ever deeper into the field of pancreas neoplasia, while keeping focus on understanding the noninvasive precursor lesions from which invasive cancers develop (PanINs and IPMNs), the familial aggregation of some pancreatic cancers, and the pathologic ramifications of genetic alterations in the pancreas. Dr. Flanagan and her collaborators have redefined the biology, pathology, and genetics of bone and soft tissue tumors. Various facilities provide the services and technology that support Memorial Sloan Ketterings cancer genomics studies. As of June 30, 2022, Dr. Klimstra is no longer an employee or consultant of Memorial Sloan Kettering. The molecular diagnostics laboratory expanded impressively under his direction. The resource provides professional expertise in pathology, appropriate samples and tissue-based experimentation. He went on to establish his own lab, without having undergone formal postdoctoral training, at the University of Michigan. These proved foreign to neuroepithelial neoplasms of other types and to reactive processes. George K. Michalopoulos, chair of the Department of Pathology, says Barnes' classifications of head and neck tumors are standards in the field and can be directly linked to therapies for those cancers. 2023 Memorial Sloan Kettering Cancer Center, Programs for college & high school students. Through his teams application of novel genomic technologies, Dr. Huntsman has contributed to the identification of ARID1A mutations and the characterization of their role in clear cell and endometrioid carcinogenesis. The effort to create the interdisciplinary CCU Neuropathology was initiated when Andreas accepted the Heidelberg offer. Over the years, Dr. Ferrell has served in multiple important roles at UCSF, including as the distinguished professor in anatomic pathology (endowed chair), vice chair of clinical affairs in the department of anatomic pathology, director of surgical pathology (2000 to 2015), director of the surgical pathology fellowship (2000 to 2014), and director of the liver and gastrointestinal pathology fellowship (2005 to 2014). Through the years, she has served a wide variety of teaching roles via USCAP. Gastrointestinal Tumors; Hepatobiliary Tumors; Pulmonary Pathology; Anatomic Pathology. Chair, Department of Medicine, George J. Bosl Chair at Memorial Sloan Kettering Cancer Center, Chair, Department of Pathology and Laboratory Medicine, Chair, Department of Psychiatry and Behavioral Sciences, PhD, RN, FAAN, Senior Vice President and Chief Nursing Executive, Senior Vice President and Chief Nursing Officer, Claire L. Tow Chair in Pediatric Oncology Research, Pursuing basic and translational research across 9 programs and 100+ labs, Focusing on clinical cancer research and population health, Bridging the lab and the clinic through translational research, Fostering interdisciplinary collaborations between laboratory scientists and clinicians, Partnering with other academic and research institutions, Offering state-of-the-art resources for our researchers, Offering a curriculum with a focus on cancer, Connecting college seniors to future careers in biomedicine, 2023 Memorial Sloan Kettering Cancer Center, Human Oncology & Pathogenesis Program (HOPP), Gerstner Sloan Kettering Graduate School of Biomedical Sciences, High school & undergraduate summer programs. Working under the direction of Dr. Jo Peters, Dr von Deimling there mapped the mouse biliverdin reductase gene. In Boston, Andreas met and partnered with Dr. David Louis, embarking on large-scale loss of heterozygosity (LOH) studies that employed the brain tumor samples collected in Zurich. His commitment to personalized cancer care embodies a key principle of modern-day medicine looking at disease through the genetic lens. NEW! Dr. Elenitoba-Johnson has been recognized with numerous awards, including the American Society for Investigative Pathology Scholarship in 1993, the Outstanding Graduating Resident Award from Brown University in 1995, the Society for Hematopathology Pathologist-in-Training Award in 1998, Outstanding Teaching Awards in Anatomic Pathology from the University of Utah (1999 and 2003), and the Ramzi S. Cotran Young Investigator Award from the United States and Canadian Academy of Pathology in 2006. Dr. Hruban is also a superb surgical pathologist and an ardent educator. He was also recruited by the WHO as a senior advisor to the formulation of the revised 4th edition of the blue book, WHO Classification of Tumours of the Central Nervous System (2016), a work that broke with a century of tradition by departing from the exclusively morphologic and building molecular genetic characteristics into the very definition of select entities. We have slides, data, and information regarding cancer diagnosis, treatment, and research spanning over 40 years and a digital archive of over 3M images. In 2007, he was named the director of the Michigan Center for Translational Pathology, the goal of which is to develop new molecular tests and therapeutics for human disease, with a primary focus on cancer. Dr. von Deimlings intellectual restlessness had him interrupting his residency and, in 1990, again making for the United States, this time to the laboratory of Dr. Bernd Seizinger in the Department of Neurosurgery and Molecular Neuro-Oncology at the Massachusetts General Hospital / Harvard Medical School. Dr. von Deimlings investiga - tions have ranged over the spectrum of neuroepithelial, meningothelial and mesenchymal neoplasms affecting children and adults, delineating genetic and epigenetic profiles that are now recognized as characteristic of diffuse gliomas, ependymomas, medulloblastomas and other embryonal tumors, choroid plexus tumors, meningiomas and neoplasms of peripheral nerve sheath origin. As evidenced by her numerous publications (more than 200 original articles), she has made great contributions to the understanding of the pathology of liver tumors, particularly of well-differentiated liver tumors, including hepatocellular adenoma variants, focal nodular hyperplasia-like lesions, vascular lesions, and malformations in the liver. From diagnosis to treatment, our experts provide the care and support you need, when you need it. Memorial Sloan-Kettering Cancer Center'sdiagnostic molecular pathology laboratory is developing a number of targeted sequencing assays to test for actionable cancer mutations and plans to run the first patient samples early next year, following certification by the New York State Department of Health. In 1988, Dr. von Deimling commenced training as a Resident in the Department of Neuropathology at the University of Zurich, Switzerland under the distinguished Paul Kleihues. Following his graduation from Jonesboro High . Contact: zzPDL_PTH_PPBC_Biobank Operation Leadership Joachim Silber, PhD / Biobank and Pathology Core Facility Director silberj@mskcc.org / Ph: 212-639-2495 Links and Resources About Us Contacts Search available services: View: by category alphabetically The Department of Pathology and Laboratory Medicine faculty includes world-class clinicians, chemists, microbiologists and infectious disease experts who collaborate with other specialists to customize patients treatments based on their individual diagnosis. His visionary approaches resulted in seminal scientific contributions that have changed the way prostate cancer is perceived, including the discovery of one of the most frequent somatic genetic alterations in human cancer the TMPRSS2-ETS fusion gene in prostate cancer and the additional driver genetic alterations in prostate cancers lacking this fusion gene. This culminated in the 2005 International Society of Urological Pathology Consensus Conference on Gleason grading, at which the international GU Pathology community, reflecting large-scale empiric experience in clinical practice, codified changes to Gleason grading. He is a native New Yorker and received his MD and PhD degrees from Stony Brook University in 2000. Seeking a more patient-focused system, in 2013, Dr. Epstein combined two significant paths of his career, prostate cancer grading and active surveillance criteria, proposing a system of prognostic grade groups, which would have the effect of simplifying clinical management conversations in very low and low risk cancers such that patients could be treated as grade group 1, rather than Gleason score 6/10. His best known and most cited work however, is the landmark 1994 JAMA study, Pathological and Clinical Findings to Predict Tumor Extent of Nonpalpable (stage T1c) Prostate Cancer, which was the first to establish formal criteria for active surveillance. His laboratory was the first to discover tumor genetic heterogeneity in glioblastoma by studying the gene amplification of receptor tyrosine kinases. Our highly-specialized educational programs shape leaders to be at the forefront of cancer care and research. It involves whole exome sequencing of prostate cancer patients to identify the role of germline variation in DNA repair pathways and other rare variants on prostate cancer survival. Post author By ; lego 75184 instructions Post date July 7, 2022; university of maryland softball . Dr. Chinnaiyan is incredibly scientifically prolific, with more than 300 papers published as of 2014, and has always proven to be a formidable collaborator, as exemplified by the numerous publications hes produced with members of MSKs Department of Pathology and many other institutions. Vice Chair for Clinical Research, Department of Surgery; Miner Family . Throughout his career, Dr. Gerald collaborated with and provided mentorship to numerous trainees and colleagues. About NRHA About Rural Health Care Rural Hospital Map Rural Health Foundation Rural Health Awards Rural Health Award winners Rural Health Award nominations . Utilizing an expansive and carefully annotated collection of neoplasms, the group demonstrated thatentities having established histologic features, genetic abnormalities and patterns of gene expression also have identifying signatures on CpG methylation array. These, as well as numerous texts and textbook chapters, including his Prostate (w/George Netto) and Bladder (w/Victor Reuter & Mahul Amin) Biopsy Diagnostic Interpretation guides are standard texts on GU Pathology and resident/fellow bookshelves. Methods. PATHOLOGY & LABORATORY MEDICINE OPPORTUNITIES, Digital Informatics & Technology Solutions. His quiet good nature and thoughtful approach made him a model physician-scientist. Ralph Hruban is a world-renowned pancreatic cancer pathology expert who has devoted his academic career to the study of pancreatic neoplasms. Anatomic Pathology David Klimstra served as the Chair of the Pathology Department and held the James Ewing Alumni Chair in Pathology from 2012-2021. This reagent has become a staple of practice across pathologic subspecialties for its obvious value in matters of tumor subclassification and in identifying candidates for BRAF inhibitor treatment. He will assume the role in early 2023. Exciting opportunity in Temple, TX for Baylor Scott & White Health as a Vice Chair of Academic Pathology. From those days date his earliest first-author efforts in the human brain tumor area, studies investigating the histogenesis and differentiating potential of central neurocytomas. What happens next? While rightly revered as a preternaturally gifted morphologist, Dr. Stewart, as dean of tumor pathologists, as James Ewings successor to the Chair of Pathology at Memorial Hospital and Founding Editor of the journal Cancer, advocated throughout his career for the application of novel technical methods to the study of neoplastic disease. Not knowing the precise uses to which such materials would be placed but realizing that assays of potential research interest such as Southern and Western blotting required non-fixed tissues, trainee von Deimling took it upon himself to begin systematically freezing CNS tumor samples coming from the operating rooms. of Pathology) State University of New York Upstate Medical University (Syracuse) University of Tennessee, Knoxville Graduate School of Medicine. He gave the 2014 United States and Canadian Academy of Pathology Timely Topics Lecture. Pathology Robert Larner, M.D. Dr. E. Leon Barnes, Jr., 81, of Bethel Park, passed away unexpectedly on Friday, February 24, 2023. Canada Research Chair Tier 1 in Systems Immunology. His arrival on the scene of prostate cancer diagnosis converged with the advent of the PSA-era and his personal efforts, together with fruitful collaborations with Drs. Michael is a practicing physician-scientist who holds an MD from Munich, Germany, and a PhD from Harvard in Biological Chemistry. His research focuses on the pathogenesis of human malignant lymphomas, biomarker discovery by genomic and proteomic profiling, and cancer. Jan 18, 2023 11:11am. The goal of this study was to examine the relationship between shoulder forces and moments experienced during wheelchair propulsion and shoulder pathology. Dr. Huntsmans creativity and infectious enthusiasm have inspired a generation of pathologists, clinicians and investigators. In the late 1990s and early 2000s, Dr. Epsteins efforts in defining the spectrum of prostate cancer variants and mimics continued unabated, including important clinicopathologic series on prostatic adenosis and foamy / atrophic / pseudohyperplastic cancers. Dr. Ferrell has lectured extensively both nationally and internationally. 11/22/2022 6:12 AM. Memorial Sloan Kettering Cancer Center See more information about the School of Physics and Astronomy at the University of Minnesota at www.physics.umn.edu Meetings . Dr. Hruban has written more than 150 book chapters and reviews, and authored or coauthored six books, including the AFIP Fascicle on Tumors of the Pancreas and the World Health Organization blue book on tumors of the digestive tract. The Department of Pathology - a collaborative team passionate about one goal: delivering the accurate scientific diagnosis in the most expert . It was then that Dr. Hruban and his colleagues took to techniques such as mutant-enriched polymerase chain reaction analysis in combination with allele-specific oligonucleotide hybridization, and revealed that KRAS mutations (now known to represent one of the few big mountains in pancreatic cancers genomic landscape) were important events in the disease. With cancer, where you get treated first matters. At Memorial Sloan Kettering Cancer Center (MSK), we have been working to establish new techniques for safe and effective lung biopsies. Dr. Powered by the most advanced technology and diagnostic techniques, this team analyzes thousands of tissue samples each year. He is an associate editor for the Journal of Hematopathology. Contact. David Klimstra served as the Chair of the Pathology Department and held the James Ewing Alumni Chair in Pathology from 2012-2021. Based in Woburn Sands, Covering Milton Keynes +50 mile radius. Most readers will be aware that chromosome 1p/19q co-deletion is now a defining feature of canonical oligodendrogliomas as codified in the 2016 World Health Organization (WHO) taxonomy of CNS neoplasms. Vice Chair of Academic Pathology. Dr. von Deimling must now make room in his trophy case for the Fred Waldorf Stewart Medal. Although one department, these two teams merge academic and education programs together to harness new knowledge and improve patient care. During this time, at Hopkins and with multi-institutional collaborative groups, Dr. Hruban produced meritorious scientific work that served both to advance pancreatic cancer research as well as to facilitate diagnosis, detection, prevention, prognosis and treatment. Location: Temple, Texas. Her contribution as the lead editor of Liver Pathology (part of the consultant pathology series from Demos Publishers), which emphasizes difficult diagnostic problems in liver pathology, has similarly offered invaluable guidance. It was been revealed in a recent NYT article that the hospital holds an equity stake in the company. His scientific and professional contributions have not only benefited patients but brought forth the central role of pathologists in this precision medicine era. Dr. Hruban joined the quest to conquer pancreatic cancer early on. The pair and their co-workers, among many original observations, would implicate chromosome 19q in the pathogenesis of diffuse gliomas and demonstrate the consistent association of allelic losses involving this and chromosome 1p with tumors exhibiting the histology of oligodendroglioma or oligoastrocytoma. Dr. Reuter graduated from Dominican Republic in 1978, and completed his training at Thomas Jefferson Univ Hosp and Meml Sloan Kettering Cancer Ctr. Importantly, his work on pancreatic intraepithelial neoplasias (PanINs) and intraductal papillary mucinous neoplasms (IPMNs), the precursor lesions that give rise to invasive pancreatic cancer, has had a particularly significant impact both in the field of pancreas research and with regard to how patients are prognosticated and managed. The PPBC is involved in evaluating novel technology for pathology research and practice. Over the past 15 years, Dr. Huntsmans research team has described most of the CDH1 mutations in families with hereditary diffuse gastric cancer and provided much of the evidence that underpins the clinical and pathologic standards of care for such families.